Conveners
KEY NOTE SESSION 2
- York Haemisch (Philips)
-
Roger Gunn (Imperial College)03/09/2014, 14:30The discovery and development of a successful CNS radiotracer is challenging and is akin to a mini drug discovery and development process itself, although with a different set of criteria (e.g. fast clearance and low bioavailability are not good for drugs but are often ideal for radioligands). Key parameters guiding tractability have previously centered on labeling feasibility, lipophilicity...Go to contribution page
-
Roger Gunn (Imperial College)03/09/2014, 15:00The discovery and development of central nervous system (CNS) drugs is a complex task that requires large investments of time and money with no guarantee of success. Currently it is estimated that it costs around €1 billion to bring each successful drug to market. Imaging techniques, such as positron emission tomography (PET), can provide important information by taking direct biological...Go to contribution page
-
Nicholas Seneca (Roche)03/09/2014, 15:30
-
York Haemisch03/09/2014, 16:00This talk will try to determine stimulating and hindering factors in the translation of research ideas and projects into new medical imaging devices. The focus will be on ideas originating from the particle physics/detector research community applied to isotope based imaging. Recent and past examples of successful and failed projects will be discussed with a special attention to the respective...Go to contribution page